IDT Biologika
Bild durch Klicken auf Symbol hinzufügen
2016
IDT BiologikaBiologics for the 21st century
2IDT Biologika Corporate Presentation
IDT Biologika, Dessau SiteIntegrated pharma- and biotechnology
3IDT Biologika Corporate Presentation
Vaccines and biologic parenteralsIDT Biologika – Two business models
Contract manufacturingDevelopment, industrialization and production of prophylactic and therapeutic products using highly efficient manufacturing technologiesLong-term international technology and manufacturing partnerships
Animal HealthInnovative, groundbreaking solutions to fight infectious diseases in animalsOwn products are marketed worldwide
4IDT Biologika Corporate Presentation
The company in facts and figures
OwnersHartmut, Carsten and Stefan Klocke via the Klocke Group
RatingInvestment Grade
8%of revenue
dedicated to research &
development
+ €200 million
revenues in 2016
1,700employees in
2016
€300 millioninvested by IDT
since 1993, €100 million between 2011 and today
WorldwideIDT works with
customers/partners around the
world
5IDT Biologika Corporate Presentation
Development of Revenues and Staff Staff Revenues
€ millionA corporate strategy with a focus on globalization and industrialization forms the basis for further growth